Heather Lau, MD, Director, Lysosomal Storage Disease Program and Associate Director, Division of Neurogenetics at NYU Langone Health, provides an overview of how to manage a person with a Pompe disease during the current COVID-19 pandemic.
Pompe disease is a rare, inherited lysosomal storage disorder caused by the buildup of a complex sugar called glycogen in the body’s cells. The accumulation of glycogen in certain organs and tissues, especially muscles, impairs their ability to function normally. Among the muscles often impacted is the diaphragm, making it important for Pompe disease patients to be managed carefully if they develop COVID-19 symptoms.
In this webinar, Dr. Lau explains the following
- Multisystemic manifestations of COVID-19
- Impact of COVID19 on Pompe disease
- Impact of COVID19 on access to therapy
- Exposure to COVID-19. What to do?
- Ethical considerations of COVID-19 in Pompe disease patients
To learn more about Pompe disease visit https://checkrare.com/pompe , http://www.amda-pompe.org/,https://www.unitedpompe.com/, or https://www.pompecanada.com/
